Molecular Pathogenesis of Osteosarcoma
Top Cited Papers
- 1 January 2007
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 26 (1) , 1-18
- https://doi.org/10.1089/dna.2006.0505
Abstract
Osteosarcoma is a devastating but rare disease, whose study has illuminated both the basic biology and clinical management of cancer over the past 30 years. These contributions have included insight into the roles of key cancer genes such as the retinoblastoma tumor suppressor gene and TP53, the identification of familial cancer syndromes implicating DNA helicases, and dramatic improvements in survival by the use of adjuvant chemotherapy. This review provides a synoptic overview of our current understanding of the molecular causes of osteosarcoma, and suggests future directions for study.Keywords
This publication has 201 references indexed in Scilit:
- Osterix enhances proliferation and osteogenic potential of bone marrow stromal cellsBiochemical and Biophysical Research Communications, 2006
- ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damageThe EMBO Journal, 2005
- Cell-Cell Interaction Mediated by Cadherin-11 Directly Regulates the Differentiation of Mesenchymal Cells Into the Cells of the Osteo-Lineage and the Chondro-LineageJournal of Bone and Mineral Research, 2004
- Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human OsteosarcomaClinical Cancer Research, 2004
- The Hallmarks of CancerCell, 2000
- Cancer Cell CyclesScience, 1996
- High-frequency developmental abnormalities in p53-deficient miceCurrent Biology, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Effects of an Rb mutation in the mouseNature, 1992